一种临床上可行的乳腺癌诊断类型,建立在同质电化学生物传感器上,用于同时多重检测
相关实验视频
Updated: Jul 30, 2026

09:30
Bacterial Detection & Identification Using Electrochemical Sensors
Published on: April 23, 2013
28.3K
Ya Zhang1, WenHao Ma1, Ning Li1
1Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing 400044, PR China.
Analytical chemistry
|August 15, 2024
概括
一种新的电化学生物传感器可以同时检测血清中的四种乳腺癌生物标志物 (ER,PR,HER2,Ki67). 这种快速的单电极平台有助于准确的乳腺癌类型和个性化治疗策略.
科学领域:
- 生物医学工程 生物医学工程
- 分析化学 分析化学
- 在瘤学瘤学.
背景情况:
- 同时检测多个瘤标志物对于准确的癌症诊断和治疗至关重要.
- 电化学同质生物传感提供高灵敏度,避免电极改造,但在多重检测方面面临挑战.
- 雌激素受体 (ER),孕激素受体 (PR),HER2和Ki67是乳腺癌分子类型的关键生物标志物.
研究的目的:
- 开发一种新的电化学同质生物平台,用于同时检测四种乳腺癌生物标志物.
- 通过使用单个电极系统,直接在人血清中同时诊断10种类型的乳腺癌.
- 建立一个快速和灵敏的方法来确定乳腺癌的分子类型,帮助个性化治疗.
主要方法:
- 使用金属离子,SiO2纳米粒子 (SiO2NPs) 和磁珠的电化学生物平台的开发.
- 在人血清中检测ER,PR,HER2和Ki67蛋白质.
- 使用单个电极进行同时检测和诊断.
主要成果:
- 生物平台实现了140分钟的短检测时间,比典型的1周临床测试时间快得多.
- 选择性检测HER2,ER,Ki67和PR被证明在0-1000 pg/mL的范围内.
- 达到了低检测极限:HER2的2 pg/mL,ER的1.8 pg/mL,Ki67的10.36 pg/mL和PR的1.33 pg/mL.
结论:
- 开发的电化学生物平台提供了一种快速,灵敏和同时检测乳腺癌关键生物标志物的方法.
- 这项技术可以直接从血清中准确地确定乳腺癌的分子类型,从而支持个性化医疗方法.
- 该平台显示了改善乳腺癌患者早期诊断和治疗计划的巨大潜力.
相关概念视频
Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Microbial Biosensors
Microbial biosensors are analytical devices that utilize living microbes to detect specific substances through measurable signals. These devices consist of two main components: biosensing organisms and signal-transducing elements. Biosensing organisms, such as Escherichia coli or Saccharomyces cerevisiae, are typically housed in multiwell plates connected to transducers, enabling rapid, real-time detection of target analytes.Signal Generation MechanismWhen a target analyte—such as...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...

